Fine Vine: Old Dog,...
Health Care: Drugs
Novogen Ltd. (NVGN: NASDAQ)
$4.04 -0.05 | -1.22%
05/17/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.09 |
| 52 Week High | 10.49 |
| 52 Week Low | 0.48 |
| Avg. Daily Vol. (Mil) | 0.23 |
| Beta (3 year) | 1.51 |
| Share Related Items | |
| Mkt Cap (Mil) | 16.98 |
| Shares Out (Mil) | 4.15 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.30 |
| Current Ratio | 3.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 12.30 |
| Price/Sales | 6.77 |
| Price/Book | 5.61 |
| Price/Cash Flow | -12.50 |
| Per Share Data | |
| Earnings | 0.33 |
| Sales | 0.60 |
| Book Value | 0.73 |
| Cash Flow | -0.33 |
| Business Summary | |
|---|---|
| Novogen Ltd. research, develops & markets pharmaceutical products. It offers its products therapeutic area cancer, heart disease, inflammatory bowel disease & other chronic inflammatory diseases & also provides health supplements. | |
| General Information | |
| Level 1
1-7 Waterloo Road North Ryde, NS 2112 |
|
| www.novogen.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 13 | |
| CEO: | |
| Short Interest | |
| Current Month (Mil) | 0.10 |
| Previous Month (Mil) | 0.10 |
| Short Interest Ratio (Days) | 0.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | 0.00 |
| Return on Investments | n.a. |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | -55.10 |
Portfolios with NVGN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- Userscjs4r speculative
Latest NVGN Headlines from TheStreet
- Tiny Biotechs Dancing in the Bull Pen 05.20.09 | 12:05 pm
- Monday's Health Winners & Losers 09.18.06 | 03:09 pm
- Friday's Health Winners & Losers 08.25.06 | 03:08 pm
- Health Stocks in Motion 07.06.04 | 05:07 pm
Press Releases for NVGN
- As Released On 30 December, 2011: Novogen Modifies ADR Program And Makes Further Investment Into Marshall Edwards - PR Newswire 01.04.12 | 05:01 pm
- Glycotex, Inc. Awarded Cash Grant Under The U.S. Government Qualifying Therapeutic Discovery Program - PR Newswire 11.24.10 | 08:11 am
- Marshall Edwards Reaches Agreement In Principle To Acquire Intellectual Property Portfolio From Novogen - PR Newswire 09.08.10 | 08:09 am
- Marshall Edwards To Host Conference Call On September 8, 2010 - PR Newswire 08.31.10 | 09:08 am
- Marshall Edwards Appoints Oncologist Christine White To Board Of Directors - PR Newswire 08.10.10 | 07:08 am
Partner Headlines for NVGN
- Morning Market Movers - Benzinga 04.03.13 | 09:04 am
- On January 3rd, Novogen to Change ADR Conversion Ratio, Similar to a 5:1 Reverse Stock Split - Benzinga 12.29.11 | 01:12 pm
- Top Buy and Sell Ideas Based on Wednesday's Biggest Gainers - Seeking Alpha 07.28.11 | 09:07 am
